RELAPSE MULTIPLE MYELOMA
Clinical trials for RELAPSE MULTIPLE MYELOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSE MULTIPLE MYELOMA trials appear
Sign up with your email to follow new studies for RELAPSE MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo shows promise for Hard-to-Treat myeloma
Disease control OngoingThis study tests a combination of four drugs (daratumumab, clarithromycin, pomalidomide, and dexamethasone) in people with multiple myeloma whose cancer returned or did not respond after prior treatment with daratumumab. The goal is to see if this combo can shrink tumors more eff…
Matched conditions: RELAPSE MULTIPLE MYELOMA
Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated May 26, 2026 07:11 UTC
-
Italian study tracks Real-World care for resistant myeloma
Knowledge-focused OngoingThis study looks at how doctors in Italy currently treat a type of blood cancer called multiple myeloma when it stops responding to three main drug classes. Researchers will collect information from medical records of about 250 patients to understand which treatments are used and…
Matched conditions: RELAPSE MULTIPLE MYELOMA
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated May 26, 2026 07:07 UTC